Singapore markets closed
Straits Times Index
3,110.73 +36.47 (+1.19%) Nikkei
32,307.86 -550.45 (-1.68%) Hang Seng
16,334.37 -11.52 (-0.07%) FTSE 100
7,554.47 +40.75 (+0.54%) Bitcoin USD
43,917.61 +232.52 (+0.53%) CMC Crypto 200
914.81 +18.10 (+2.02%)
BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.17B |
| Enterprise value | 1.61B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 3.38 |
| Price/book (mrq) | 56.59 |
| Enterprise value/revenue | 5.08 |
| Enterprise value/EBITDA | -13.14 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.87 |
| 52-week change 3 | -48.83% |
| S&P500 52-week change 3 | 15.38% |
| 52-week high 3 | 12.08 |
| 52-week low 3 | 4.83 |
| 50-day moving average 3 | 5.76 |
| 200-day moving average 3 | 7.26 |
Share statistics
| Avg vol (3-month) 3 | 3.4M |
| Avg vol (10-day) 3 | 5.17M |
| Shares outstanding 5 | 204.81M |
| Implied shares outstanding 6 | 204.81M |
| Float 8 | 174.58M |
| % held by insiders 1 | 1.11% |
| % held by institutions 1 | 88.76% |
| Shares short (14 Nov 2023) 4 | 29.47M |
| Short ratio (14 Nov 2023) 4 | 7.71 |
| Short % of float (14 Nov 2023) 4 | 16.01% |
| Short % of shares outstanding (14 Nov 2023) 4 | 14.39% |
| Shares short (prior month 12 Oct 2023) 4 | 44.19M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | -74.43% |
| Operating margin (ttm) | -13.74% |
Management effectiveness
| Return on assets (ttm) | -12.41% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 317.56M |
| Revenue per share (ttm) | 1.68 |
| Quarterly revenue growth (yoy) | 14.40% |
| Gross profit (ttm) | 10.94M |
| EBITDA | -105.72M |
| Net income avi to common (ttm) | -236.35M |
| Diluted EPS (ttm) | -1.25 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 397.59M |
| Total cash per share (mrq) | 1.94 |
| Total debt (mrq) | 845.43M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 5.54 |
| Book value per share (mrq) | -2.16 |
Cash flow statement
| Operating cash flow (ttm) | -110.07M |
| Levered free cash flow (ttm) | -95.71M |
© 2023 Yahoo. All rights reserved.